Spinal cord astrocytoma: Response to PCV chemotherapy

John W. Henson; Allan F. Thornton; David N. Louis

doi:10.1212/wnl.54.2.518

Spinal cord astrocytoma: Response to PCV chemotherapy

John W. Henson, Allan F. Thornton, David N. Louis

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.

Original language	English (US)
Pages (from-to)	518-520
Number of pages	3
Journal	Neurology
Volume	54
Issue number	2
DOIs	https://doi.org/10.1212/wnl.54.2.518
State	Published - Jan 25 2000
Externally published	Yes

Keywords

Astrocytoma
Chemotherapy
Spinal neoplasm

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/wnl.54.2.518

Cite this

@article{b4b62385ac75494b8b8d237a66200c30,

title = "Spinal cord astrocytoma: Response to PCV chemotherapy",

abstract = "Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.",

keywords = "Astrocytoma, Chemotherapy, Spinal neoplasm",

author = "Henson, {John W.} and Thornton, {Allan F.} and Louis, {David N.}",

year = "2000",

month = jan,

day = "25",

doi = "10.1212/wnl.54.2.518",

language = "English (US)",

volume = "54",

pages = "518--520",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Spinal cord astrocytoma

T2 - Response to PCV chemotherapy

AU - Henson, John W.

AU - Thornton, Allan F.

AU - Louis, David N.

PY - 2000/1/25

Y1 - 2000/1/25

N2 - Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.

AB - Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.

KW - Astrocytoma

KW - Chemotherapy

KW - Spinal neoplasm

UR - http://www.scopus.com/inward/record.url?scp=0034711671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034711671&partnerID=8YFLogxK

U2 - 10.1212/wnl.54.2.518

DO - 10.1212/wnl.54.2.518

M3 - Article

C2 - 10668731

AN - SCOPUS:0034711671

SN - 0028-3878

VL - 54

SP - 518

EP - 520

JO - Neurology

JF - Neurology

IS - 2

ER -

Spinal cord astrocytoma: Response to PCV chemotherapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this